4-[(1,3-benzothiazol-2-ylthio)methyl]benzoic acid, 95.0%, 2.5g

5-(Oxazol-5-yl)thiophene-2-sulfonyl chloride, 97%, 50mg

(+/-)-camphor, min. 95%, 500 g, plastic packaging.

Tin foil 99.99% 1.0 x 100 x 100 mm 1 pc

1-(3-Chloro-4-methylphenyl)-3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)urea, 97.00%, 250mg

Di-(N-succinimidyl) adipate 50 g

N-(9,9-Dimethyl-9H-fluoren-2-yl)-9,9-diphenyl-9H-fluoren-2-amine>98.0%(HPLC)(N)5g

Metronidazole Benzoate, 98%, 100g

4,4'-Dimethyl-2,2'-bipyridyl>98.0%(GC)(T)5g

3-acetyl-6-chloro-4-(4-methylphenyl)quinolin-2(1H)-one, 95.0%, 250mg

Triruthenium Dodecacarbonyl1g

2-Hydroxy-3-iodobenzaldehyde, 95.0%, 1g